↓ Skip to main content

Targeted therapy in advanced non-small cell lung cancer: current advances and future trends

Overview of attention for article published in Journal of Hematology & Oncology, July 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

news
1 news outlet
policy
1 policy source
twitter
11 X users
reddit
1 Redditor

Readers on

mendeley
185 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Targeted therapy in advanced non-small cell lung cancer: current advances and future trends
Published in
Journal of Hematology & Oncology, July 2021
DOI 10.1186/s13045-021-01121-2
Pubmed ID
Authors

Umair Majeed, Rami Manochakian, Yujie Zhao, Yanyan Lou

X Demographics

X Demographics

The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 185 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 185 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 20 11%
Student > Ph. D. Student 15 8%
Student > Master 15 8%
Student > Bachelor 15 8%
Student > Doctoral Student 9 5%
Other 26 14%
Unknown 85 46%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 34 18%
Medicine and Dentistry 24 13%
Pharmacology, Toxicology and Pharmaceutical Science 9 5%
Agricultural and Biological Sciences 8 4%
Unspecified 5 3%
Other 17 9%
Unknown 88 48%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 October 2022.
All research outputs
#1,823,540
of 24,608,500 outputs
Outputs from Journal of Hematology & Oncology
#132
of 1,265 outputs
Outputs of similar age
#43,736
of 430,473 outputs
Outputs of similar age from Journal of Hematology & Oncology
#9
of 45 outputs
Altmetric has tracked 24,608,500 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,265 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.3. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 430,473 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 45 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.